Genmab A/S ( GNMSF) - Stock Earnings
GNMSF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 31.1 million USD | 1.1 billion USD |
| 2026Q1 | 53.0 million USD | 896.0 million USD |
| 2026Q2 | 296.8 million USD | 1.1 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
GNMSF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 4.4 billion USD | 16.5 billion USD |
| 2024 | 7.8 billion USD | 21.5 billion USD |
| 2025 | 996.9 million USD | 3.9 billion USD |
| 2026 Est. | — | — |
GNMSF
Price: $320
52 week price:
Earnings Per Share: 12.65 USD
P/E Ratio: 24.63
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 19.4 billion